Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Working Capital to Net Assets Ratio
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Working Capital to Net Assets ratio of -50.4% as of March 2026. Working capital of CN¥-48.92 Million (current assets of CN¥256.59 Million minus current liabilities of CN¥305.51 Million) is measured against net assets of CN¥97.08 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Hangzhou TianMuShan Pharmaceutical Enter (600671) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Working Capital to Net Assets (1993–2025)
This chart shows how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's Working Capital to Net Assets ratio has evolved across 32 annual periods from 1993 to 2025. As of March 2026, the ratio stands at -50.4%, reflecting working capital of CN¥-48.92 Million against net assets of CN¥97.08 Million CNY. For the complete balance sheet picture, see Hangzhou TianMuShan Pharmaceutical Enter balance sheet assets.
Annual Working Capital to Net Assets for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1993–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1993 to 2025, covering 32 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Hangzhou TianMuShan Pharmaceutical Enter (600671) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -57.4% | CN¥-53.95 Million | CN¥93.99 Million | CN¥228.48 Million | CN¥282.42 Million | ▲ +17.5 pp |
| 2024 | -74.9% | CN¥-63.67 Million | CN¥85.02 Million | CN¥222.71 Million | CN¥286.38 Million | ▼ -5.4 pp |
| 2023 | -69.5% | CN¥-38.88 Million | CN¥55.95 Million | CN¥181.50 Million | CN¥220.38 Million | ▲ +2097.8 pp |
| 2022 | -2167.3% | CN¥-97.09 Million | CN¥4.48 Million | CN¥124.13 Million | CN¥221.22 Million | ▼ -2066.5 pp |
| 2021 | -100.8% | CN¥-65.08 Million | CN¥64.56 Million | CN¥186.08 Million | CN¥251.15 Million | ▼ -69.8 pp |
| 2020 | -31.0% | CN¥-28.96 Million | CN¥93.33 Million | CN¥222.92 Million | CN¥251.89 Million | ▼ -77.3 pp |
| 2019 | 46.3% | CN¥61.70 Million | CN¥133.33 Million | CN¥266.35 Million | CN¥204.65 Million | ▲ +64.0 pp |
| 2018 | -17.7% | CN¥-14.48 Million | CN¥81.62 Million | CN¥262.23 Million | CN¥276.70 Million | ▲ +7.6 pp |
| 2017 | -25.4% | CN¥-24.43 Million | CN¥96.27 Million | CN¥226.07 Million | CN¥250.50 Million | ▲ +105.2 pp |
| 2016 | -130.6% | CN¥-86.44 Million | CN¥66.18 Million | CN¥115.32 Million | CN¥201.76 Million | ▼ -0.2 pp |
| 2015 | -130.4% | CN¥-81.84 Million | CN¥62.76 Million | CN¥101.29 Million | CN¥183.13 Million | ▼ -88.5 pp |
| 2014 | -42.0% | CN¥-35.76 Million | CN¥85.25 Million | CN¥127.30 Million | CN¥163.06 Million | ▼ -29.3 pp |
| 2013 | -12.6% | CN¥-12.02 Million | CN¥95.26 Million | CN¥184.79 Million | CN¥196.81 Million | ▲ +30.3 pp |
| 2012 | -42.9% | CN¥-39.84 Million | CN¥92.76 Million | CN¥159.61 Million | CN¥199.45 Million | ▼ -67.5 pp |
| 2011 | 24.5% | CN¥44.86 Million | CN¥182.84 Million | CN¥219.06 Million | CN¥174.20 Million | ▲ +16.5 pp |
| 2010 | 8.0% | CN¥12.33 Million | CN¥154.14 Million | CN¥177.19 Million | CN¥164.86 Million | ▼ -15.4 pp |
| 2009 | 23.4% | CN¥43.93 Million | CN¥187.74 Million | CN¥183.66 Million | CN¥139.73 Million | ▼ -24.3 pp |
| 2008 | 47.7% | CN¥114.53 Million | CN¥240.30 Million | CN¥242.51 Million | CN¥127.98 Million | ▼ -2.8 pp |
| 2007 | 50.5% | CN¥142.90 Million | CN¥282.93 Million | CN¥270.98 Million | CN¥128.08 Million | ▼ -0.1 pp |
| 2006 | 50.6% | CN¥119.55 Million | CN¥236.44 Million | CN¥234.78 Million | CN¥115.24 Million | ▼ -0.3 pp |
| 2005 | 50.9% | CN¥121.79 Million | CN¥239.39 Million | CN¥254.31 Million | CN¥132.52 Million | ▼ -2.8 pp |
| 2004 | 53.7% | CN¥135.54 Million | CN¥252.36 Million | CN¥240.23 Million | CN¥104.69 Million | ▲ +2.1 pp |
| 2003 | 51.6% | CN¥125.16 Million | CN¥242.64 Million | CN¥228.64 Million | CN¥103.48 Million | ▲ +5.6 pp |
| 2002 | 46.0% | CN¥116.41 Million | CN¥253.20 Million | CN¥236.74 Million | CN¥120.32 Million | ▼ -1.1 pp |
| 2001 | 47.0% | CN¥118.39 Million | CN¥251.63 Million | CN¥275.51 Million | CN¥157.11 Million | ▲ +1.0 pp |
| 2000 | 46.1% | CN¥115.79 Million | CN¥251.29 Million | CN¥270.38 Million | CN¥154.60 Million | ▼ -1.9 pp |
| 1999 | 48.0% | CN¥117.22 Million | CN¥244.10 Million | CN¥212.79 Million | CN¥95.58 Million | ▲ +3.3 pp |
| 1998 | 44.8% | CN¥105.51 Million | CN¥235.71 Million | CN¥192.53 Million | CN¥87.02 Million | ▼ -0.4 pp |
| 1997 | 45.2% | CN¥101.77 Million | CN¥225.25 Million | CN¥172.04 Million | CN¥70.27 Million | ▼ -4.0 pp |
| 1996 | 49.2% | CN¥99.08 Million | CN¥201.52 Million | CN¥154.93 Million | CN¥55.85 Million | ▲ +15.6 pp |
| 1995 | 33.6% | CN¥58.45 Million | CN¥174.02 Million | CN¥147.34 Million | CN¥88.89 Million | ▼ -19.8 pp |
| 1993 | 53.4% | CN¥46.20 Million | CN¥86.48 Million | CN¥68.88 Million | CN¥22.68 Million | — |